Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Aug 22 - Aug 27
Gliflozins in the management of cardiovascular disease
Implementation Science: Why Should We Care
References Ghigo, Ezio, et al
Theyre all part of a multi district lawsuit going before a Philadelphia judge
a Mean change from baseline adjusted for baseline A1C, geographical region, and eGFT at baseline
Third, as we will detail below (see Potential Pathogenic Mechanisms of Hyperhomocysteinemia), our own work (Durand et al, 1997a) and the work of Lentz et al (1996) and Bellamy et al (1998) give experimental evidence that moderate hyperhomocysteinemia, which leads to vascular dysfunction, might increase the cardiovascular risk independently of other risk factors
US$ 29.69
US$ 23.52
US$ 20.72
US$ 25.54
US$ 27.92
US$ 28.26
